Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by staff Oct 30, 2023
Tricuspid Valve Replacement Safe, Effective in Pivotal Trial Outcome data still awaited after positive interim results Oct 27, 2023
Another Study Highlights Metformin's Dementia Protection Properties Association appeared irrespective of HbA1c level Oct 25, 2023
Cruise Line Found Negligent About COVID; Dialysis Machine Recall; MRI Injures Nurse Health news and commentary from around the Web gathered by staff Oct 25, 2023
Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials Oct 24, 2023
CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetes Health news and commentary from around the Web gathered by staff Oct 20, 2023
Highly Potent Statin Stands Out for Diabetes, Cataract Risks Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
How to Deprescribe Dialysis After Patients Leave the Hospital Acute kidney injury patients should not be left on dialysis longer than necessary Oct 19, 2023
FDA Approves First Phosphate Absorption Inhibitor for CKD Tenapanor indicated for adults on dialysis who fail on phosphate binders Oct 18, 2023
Antibiotic Combo for Acute Infection Cleared of Kidney Risk Use of cefepime meanwhile resulted in more neurological dysfunction Oct 16, 2023
'Surprising' Contribution of Pulmonary Hypertension to ARDS Outcomes Coexisting conditions spell markedly poor clinical course Oct 12, 2023
Modest Risks Come With Moving Fast on HF Drugs After Acute Event STRONG-HF analysis details the impact Oct 10, 2023
Risk of Contrast Media Causing Acute Kidney Injury Is Overblown, Study Finds Despite restrictions on its use, an association with kidney injury hasn't been shown Oct 10, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
Adherence Matters for CVD Secondary Prevention in CPAP Users Questionable benefit may hinge on number of hours used Oct 05, 2023
Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failure Mortality predicted by cumulative hsCRP levels over time Oct 02, 2023
FDA OKs Another Injectable for Rare Kidney Disorder Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
Reassuring Registry Data on Going Into TAVR Sans Symptoms Would intervention beat watchful waiting for asymptomatic patients with severe aortic stenosis? Sep 20, 2023
Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
No Avoiding Mitral Valve Implant Obstruction With Preemptive Ablation LVOT obstruction remains thorn in the side of TMVI in small case series Sep 15, 2023
Fresh Blood Not Always the Best Blood? French study assesses red blood cell transfusions and kidney transplant outcomes Sep 14, 2023
FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy Clinical meaningfulness is a different question, however Sep 13, 2023
Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by staff Sep 12, 2023
One PrEP Regimen Linked to Higher Risk of Hypertension, Statin Use Over Another Use of TAF associated with increased risks within 2 years versus TDF, retrospective study finds Sep 11, 2023
When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
Lorundrostat Stands a Chance Against Obesity-Related Hypertension Selective aldosterone synthase inhibitor proceeds to phase III study after Target-HTN's success Sep 10, 2023
